Rebuilding the Hazardous Drug List:

Charlotte A. Smith, RPh, MSSenior Regulatory AdvisorRanee Runnebaum, PharmDManager, Regulatory and ComplianceKathleen Skibinski, RPh, MSRegulatory ConsultantWMHS PharmEcology ServicesThe National Institute for Occupational Safety and Health (NIOSH) Hazardous Drug List 20241 is the most recent official publication to delineate hazardous drugs in the United States. Although it provides a solid framework for moving drug evaluations forward, it has not been updated to include drugs approved in the l